Objective This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0–6 years) with recent contact with an index tuberculosis case. Materials and Methods A cross-sectional study including 135 children was conducted in Manaus, Amazonas-Brazil. The TST and QFT were performed and the tests results were analyzed in relation to the personal characteristics of the children studied and their relationship with the index case. Results The rates of positivity were 34.8% (TST) and 26.7% (QFT), with 14.1% of indeterminations by the QFT. Concordance between tests was fair (Kappa = 0.35 P<0.001). Both the TST and QFT were associated with the intensity of exposure (Linear OR = 1.286, P = 0.005; Linear OR = 1.161, P = 0.035 respectively) with only the TST being associated with the time of exposure (Linear OR = 1.149, P = 0.009). The presence of intestinal helminths in the TST+ group was associated with negative QFT results (OR = 0.064, P = 0.049). In the TST？ group lower levels of ferritin were associated with QFT+ results (Linear OR = 0.956, P = 0.036). Conclusions Concordance between the TST and QFT was lower than expected. The factors associated with the discordant results were intestinal helminths, ferritin levels and exposure time to the index tuberculosis case. In TST+ group, helminths were associated with negative QFT results suggesting impaired cell-mediated immunity. The TST？&QFT+ group had a shorter exposure time and lower ferritin levels, suggesting that QFT is faster and ferritin may be a potential biomarker of early stages of tuberculosis infection.
References
[1]
World Health Organization (2011) Global tuberculosis control 2011. Geneve: WHO. Available: http://www.who.int/tb/publications/globa？l_report/en/index.html. Accessed 2012 July 22.
[2]
Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, et al. (2004) The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8: 392–402.
[3]
Starke JR (2003) Pediatric tuberculosis: time for a new approach. Tuberculosis (Edinb) 83: 208–212.
[4]
Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children (2006) Int J Tuberc Lung Dis. 10: 1091–1097.
[5]
Pai M, Riley LW, Colford JM (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet InfectDis 4: 761–776.
[6]
Comstock GW, Livesay VT, Woolpert SF (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99: 131–138.
[7]
Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192–1204.
[8]
Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761–776 doi:10.1016/S1473-3099(04)01206-X.
[9]
Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, et al. (2011) The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 30: 694–700 doi:10.1097/INF.0b013e318214b915.
[10]
Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, et al. (2009) Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64: 840–846 doi:10.1136/thx.2007.085340.
[11]
World Health Organization. The WHO Child Growth Standards. WHO. Available: http://www.who.int/childgrowth/standards？/en/. Accessed 2012 May 1.
[12]
Lutz A (1919) Schistosomum mansoni and Schistosomatosis observed in Brazil. Mem Inst Oswaldo Cruz: 121–155.
[13]
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159–174.
[14]
Powell DA (2009) Interferon Gamma Release Assays in the Evaluation of Children With Possible Mycobacterium tuberculosis Infection: A View to Caution. Pediatr Infect Dis J 28: 676–677.
[15]
Dheda K, van Zyl Smit R, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188–200 doi:10.1097/MCP.0b013e32832a0adc.
[16]
Hill PC, Brookes RH, Adetifa IM, Fox A, Jackson-Sillah D, et al. (2006) Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 117: 1542–1548.
[17]
Almeida LM, Barbieri MA, Da Paix？o AC, Cuevas LE (2001) Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage. Pediatr Infect Dis J 20: 1061–1065.
[18]
Raharimanga V, Ratovoson R, Ratsitorahina M, Ramarokoto H, Rasolofo V, et al. (2012) Tuberculin reactivity in first-year schoolchildren in Madagascar. Trop Med Int Health 17: 871–876 doi:10.1111/j.1365-3156.2012.03013.x.
[19]
Hill PC, Ota MOC (2010) Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases. Lancet Infect Dis 10: 723–732 doi:10.1016/S1473-3099(10)70164-X.
[20]
Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence K-A, et al. (2011) Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS ONE 6: e18206 doi:10.1371/journal.pone.0018206.
[21]
Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, et al. (2009) T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13: 84–92.
[22]
Resende CT, Hirsch CS, Toossi Z, Dietze R, Ribeiro-Rodrigues R (2007) Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol 147: 45–52.
[23]
Pai M, Kalantri S, Menzies D (2006) Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 10: 942–943.
[24]
Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D (2011) Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 15: 1018–1032 doi:10.5588/ijtld.10.0631.
[25]
Thomas TA, Mondal D, Noor Z, Liu L, Alam M, et al. (2010) Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics 126: e1522–1529 doi:10.1542/peds.2010-0885.
[26]
Banfield S, Pascoe E, Thambiran A, Siafarikas A, Burgner D (2012) Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis. PLoS ONE 7: e38556 doi:10.1371/journal.pone.0038556.
[27]
Lewinsohn DA, Lewinsohn DM (2008) Immunologic susceptibility of young children to Mycobacterium tuberculosis. PediatrRes 63: 115.
[28]
Borkow G, Leng Q, Weisman Z, Stein M, Galai N, et al. (2000) Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 106: 1053–1060 doi:10.1172/JCI10182.
[29]
Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R (2002) Intestinal nematodes and pulmonary tuberculosis. Rev Soc Bras Med Trop 35: 533–535.
[30]
Pai M, O’Brien R (2007) Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 4: e208 doi:10.1371/journal.pmed.0040208.
[31]
Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 4: e192 doi:10.1371/journal.pmed.0040192.
[32]
Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EEM, et al. (2008) T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE 3: e1850 doi:10.1371/journal.pone.0001850.
[33]
Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I (1991) Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 59: 1905–1910.
[34]
Haile Y, Bjune G, Wiker HG (2002) Expression of the mceA, esat-6 and hspX genes in Mycobacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply. Microbiology (Reading, Engl) 148: 3881–3886.
[35]
Thom RE, Elmore MJ, Williams A, Andrews SC, Drobniewski F, et al. (2012) The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge. Vaccine 30: 3159–3168 doi:10.1016/j.vaccine.2012.03.008.
[36]
Manabe YC, Saviola BJ, Sun L, Murphy JR, Bishai WR (1999) Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proc Natl Acad Sci USA 96: 12844–12848.
[37]
Basaraba RJ, Bielefeldt-Ohmann H, Eschelbach EK, Reisenhauer C, Tolnay AE, et al. (2008) Increased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pig. Tuberculosis (Edinb) 88: 69–79 doi:10.1016/j.tube.2007.09.002.
[38]
Ratledge C (2004) Iron, mycobacteria and tuberculosis. Tuberculosis(Edinb) 84: 110–130.
[39]
Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161–203.
[40]
Isanaka S, Aboud S, Mugusi F, Bosch RJ, Willett WC, et al. (2012) Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS ONE 7: e37350 doi:10.1371/journal.pone.0037350.
[41]
Reddy PV, Puri RV, Khera A, Tyagi AK (2012) Iron storage proteins are essential for the survival and pathogenesis of Mycobacterium tuberculosis in THP-1 macrophages and the guinea pig model of infection. J Bacteriol 194: 567–575 doi:10.1128/JB.05553-11.
[42]
Friis H, Range N, Braendgaard KC, Kaestel P, Changalucha J, et al. (2009) Acute- phase response and iron status markers among pulmonary tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. BrJNutr 102: 310–317.
[43]
Bergamini BM, Losi M, Vaienti F, D’Amico R, Meccugni B, et al. (2009) Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 123: e419–424 doi:10.1542/peds.2008-1722.
[44]
Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, et al. (2008) A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoSONE 3: e2624.
[45]
Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, et al. (2009) The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 28: 669–673 doi:10.1097/INF.0b013e3181a16394.
[46]
Grare M, Derelle J, Dailloux M, Laurain C (2010) QuantiFERON-TB Gold In-Tube as help for the diagnosis of tuberculosis in a French pediatric hospital. Diagn Microbiol Infect Dis 66: 366–372 doi:10.1016/j.diagmicrobio.2009.11.002.
[47]
Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85: 613–621 doi:10.1007/s00109-007-0157-6.
